BioLife Solutions Inc., a leading developer and supplier of bioproduction products and services for the cell and gene therapy market, is set to participate in the 22nd Annual Craig-Hallum Institutional Investor Conference on May 28, 2025, in Minneapolis, MN, at the Renaissance Hotel. Information about their presentation at the event is not specified in the document.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.